Century Therapeutics, Inc. (IPSC) Operating income 2020–2025
Century Therapeutics, Inc. (IPSC) annual operating income history from SEC filings — each fiscal year as reported.
-$17.3MFY2025 · since FY2020: -$53.9M → -$17.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$17.3M | +87.5% |
| FY2024 | -$138.1M | +5.7% |
| FY2023 | -$146.5M | -9.5% |
| FY2022 | -$133.8M | -41.0% |
| FY2021 | -$94.9M | -76.0% |
| FY2020 | -$53.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IPSC financial trends
IPSC RevenueIPSC Net incomeIPSC Net marginIPSC Gross profitIPSC Gross marginIPSC Operating marginIPSC Operating cash flowIPSC Free cash flowIPSC Capital expendituresIPSC Return on equityIPSC Stock buybacksIPSC Dividends paidIPSC Total assetsIPSC Total liabilitiesIPSC Shareholders’ equityIPSC overview →